Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).

Band, C J

Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen). [electronic resource] - Molecular endocrinology (Baltimore, Md.) Dec 1997 - 1899-910 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0888-8809

10.1210/mend.11.13.0041 doi


Animals
Carcinoma, Hepatocellular
Dose-Response Relationship, Drug
Drug Synergism
Enzyme Activation--drug effects
Humans
Insulin--pharmacology
Insulin Receptor Substrate Proteins
Intracellular Signaling Peptides and Proteins
Liver Neoplasms
Organometallic Compounds--pharmacology
Phenanthrolines--pharmacology
Phosphatidylinositol 3-Kinases--drug effects
Phosphoproteins--drug effects
Phosphorylation--drug effects
Precipitin Tests
Protein Tyrosine Phosphatase, Non-Receptor Type 11
Protein Tyrosine Phosphatase, Non-Receptor Type 6
Protein Tyrosine Phosphatases--antagonists & inhibitors
Rats
Receptor, Insulin--antagonists & inhibitors
Recombinant Fusion Proteins
SH2 Domain-Containing Protein Tyrosine Phosphatases
Signal Transduction--drug effects
Substrate Specificity--drug effects
Tumor Cells, Cultured
Tyrosine--metabolism
src Homology Domains--drug effects